limiting the use of OTC cough and cold medicines in young children

January 2011

New evidence verifies the benefit of limiting the use of OTC cough and cold medicines in young children.

The infant versions are no longer marketed...and the remaining children's products are no longer labeled for children under age 4 or 6.

Now a new report suggests this is making a big difference.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote